Showing results (171-180 of 306) with videos related to
Sort By:
Pageof 31
Blood|April 1, 1988
Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemiaJ E Sanders, C D Buckner, E D Thomas, et al.Experimental Hematology|May 1, 1976
Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemiaB Speck, P Cornu, M Jeannet, et al.The Journal of Clinical Investigation|March 1, 1988
Antigen CD34+ marrow cells engraft lethally irradiated baboonsR J Berenson, R G Andrews, W I Bensinger, et al.Progress in Clinical and Biological Research|January 1, 1987
Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantationK M Sullivan, A Fefer, R Witherspoon, et al.Transplantation|August 1, 1981
Studies of the response in mixed leukocyte culture of cells from patients with aplastic anemia to cells from HLA-identical siblingsE M Mickelson, R A Clift, A Fefer, et al.The New England Journal of Medicine|February 15, 1979
Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twinA Fefer, M A Cheever, E D Thomas, et al.Bone Marrow Transplantation|April 1, 1997
Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centersC H Weaver, L S Schwartzberg, J Hainsworth, et al.American Journal of Clinical Oncology|April 13, 1999
Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell supportL S Schwartzberg, C H Weaver, R Birch, et al.Bone Marrow Transplantation|March 1, 1996
Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancyC Massumoto, M C Benyunes, G Sale, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancerT Demirer, S Rowley, C D Buckner, et al.Pageof 31